DexCom, Insulet to integrate technologies

 - 
Wednesday, February 19, 2020

SAN DIEGO – DexCom and Insulet Corporation have partnered to combine current and future Dexcom CGMs with Insulet’s tubeless insulin delivery Pod into the Omnipod Horizon System, which is currently in trial. Under terms of the non-exclusive agreement, the Omnipod Horizon Automated Insulin Delivery (AID) System will use sensor values from the Dexcom G6 and next generation G7 CGM systems to predict glucose levels into the future and automatically adjust insulin doses. “Everyone at Dexcom is excited to be in the final stages of integrating Dexcom CGM technology into the Omnipod Horizon System," said Kevin Sayer, executive chairman, president and CEO of Dexcom. "This system will bring together the demonstrated accuracy of Dexcom CGM with Omnipod’s tubeless insulin delivery Pod which provides a simple user experience and freedom from injections and tubes.”